These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 12047482

  • 21. [Role of food interaction pharmacokinetic studies in drug development. Food interaction studies of theophylline and nifedipine retard and buspirone tablets].
    Drabant S, Klebovich I, Gachályi B, Renczes G, Farsang C.
    Acta Pharm Hung; 1998 Sep; 68(5):294-306. PubMed ID: 9805816
    [Abstract] [Full Text] [Related]

  • 22. Can dosage form-dependent food effects be predicted using biorelevant dissolution tests? Case example extended release nifedipine.
    Andreas CJ, Tomaszewska I, Muenster U, van der Mey D, Mueck W, Dressman JB.
    Eur J Pharm Biopharm; 2016 Aug; 105():193-202. PubMed ID: 27322002
    [Abstract] [Full Text] [Related]

  • 23. Effects of Food Intake on the Relative Bioavailability of Amifampridine Phosphate Salt in Healthy Adults.
    Haroldsen PE, Musson DG, Hanson B, Quartel A, O'Neill CA.
    Clin Ther; 2015 Jul 01; 37(7):1555-63. PubMed ID: 26101174
    [Abstract] [Full Text] [Related]

  • 24. Application of the GastroDuo to study the interplay of drug release and gastric emptying in case of immediate release Aspirin formulations.
    Schick P, Sager M, Voelker M, Weitschies W, Koziolek M.
    Eur J Pharm Biopharm; 2020 Jun 01; 151():9-17. PubMed ID: 32268191
    [Abstract] [Full Text] [Related]

  • 25. The effects of food on the bioavailability of fenofibrate administered orally in healthy volunteers via sustained-release capsule.
    Yun HY, Joo Lee E, Youn Chung S, Choi SO, Kee Kim H, Kwon JT, Kang W, Kwon KI.
    Clin Pharmacokinet; 2006 Jun 01; 45(4):425-32. PubMed ID: 16584288
    [Abstract] [Full Text] [Related]

  • 26. Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system. A controlled-release formulation of nifedipine.
    Chung M, Reitberg DP, Gaffney M, Singleton W.
    Am J Med; 1987 Dec 21; 83(6B):10-4. PubMed ID: 3503594
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Pharmacokinetics of a New Amphetamine Extended-release Oral Liquid Suspension Under Fasted and Fed Conditions in Healthy Adults: A Randomized, Open-label, Single-dose, 3-treatment Study.
    Sikes C, Stark JG, McMahen R, Engelking D.
    Clin Ther; 2017 Dec 21; 39(12):2389-2398. PubMed ID: 29174216
    [Abstract] [Full Text] [Related]

  • 30. Lamivudine/zidovudine as a combined formulation tablet: bioequivalence compared with lamivudine and zidovudine administered concurrently and the effect of food on absorption.
    Moore KH, Shaw S, Laurent AL, Lloyd P, Duncan B, Morris DM, O'Mara MJ, Pakes GE.
    J Clin Pharmacol; 1999 Jun 21; 39(6):593-605. PubMed ID: 10354963
    [Abstract] [Full Text] [Related]

  • 31. Relative bioavailability study of two nifedipine tablet formulations in healthy male volunteers.
    Niopas I, Daftsios AC, Xanthakis I, Nikolaidis N.
    Int J Clin Pharmacol Ther; 2000 Jun 21; 38(6):309-14. PubMed ID: 10890580
    [Abstract] [Full Text] [Related]

  • 32. Abacavir/lamivudine/zidovudine as a combined formulation tablet: bioequivalence compared with each component administered concurrently and the effect of food on absorption.
    Yuen GJ, Lou Y, Thompson NF, Otto VR, Allsup TL, Mahony WB, Hutman HW.
    J Clin Pharmacol; 2001 Mar 21; 41(3):277-88. PubMed ID: 11269568
    [Abstract] [Full Text] [Related]

  • 33. Effects of food intake on the pharmacokinetic properties of mirabegron oral controlled-absorption system: a single-dose, randomized, crossover study in healthy adults.
    Lee J, Zhang W, Moy S, Kowalski D, Kerbusch V, van Gelderen M, Sawamoto T, Grunenberg N, Keirns J.
    Clin Ther; 2013 Mar 21; 35(3):333-41. PubMed ID: 23497763
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Single-dose bioequivalence of 105-mg fenofibric acid tablets versus 145-mg fenofibrate tablets under fasting and fed conditions: a report of two phase I, open-label, single-dose, randomized, crossover clinical trials.
    Godfrey AR, Digiacinto J, Davis MW.
    Clin Ther; 2011 Jun 21; 33(6):766-75. PubMed ID: 21704241
    [Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics and therapeutic effect of OROS methylphenidate under different breakfast conditions in children with attention-deficit/hyperactivity disorder.
    Wigal SB, Gupta S, Heverin E, Starr HL.
    J Child Adolesc Psychopharmacol; 2011 Jun 21; 21(3):255-63. PubMed ID: 21663428
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials.
    Metzmann K, Schnell D, Jungnik A, Ring A, Theodor R, Hohl K, Meinicke T, Friedrich C.
    Int J Clin Pharmacol Ther; 2014 Jul 21; 52(7):549-63. PubMed ID: 24755124
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.